Abstract 2136P
Background
Prostate cancer (PC) patients face treatment-related sequelae that affect their health and quality of life. The PCSC Program was created in 2013 and is located in the Vancouver Prostate Centre’s urology clinic. It is a clinical, educational, and research-based program that addresses challenges experienced by PC patients from the time of diagnosis onward. The program consists of 8 “modules” listed in the table.
Methods
We describe the operational details of the PCSC Program and its metrics.
Results
A Medical Director and Program Manager set the mission, oversee the day-to-day operations, and hire and manage the allied health clinicians and support staff. Office/clinic space is rotated during the week to accommodate a sexual health RN (1.4 FTE), 2 pelvic floor physiotherapists, a nurse practitioner, a registered dietitian, a clinical exercise physiologist (all 0.2 FTE), and a clinical counsellor (0.4 FTE). As of 05/2023, 3351 pts have registered for this no-cost program (Table). In 4/2020, the real-time group education sessions and clinic appointments transitioned from in-person to a hybrid with virtual options enabling the participation of patients from throughout British Columbia.
Table: 2136P
Attendance at PCSC modules for 3351 registrants from 2013 to May 2023
Modules | Attendees, n | Group education*, n (# sessions) | Clinic appointments, n (# appointments) |
Introduction to PC and primary treatment options | 945 | 955 (159) | not applicable |
Managing sexual function and intimacy | 1745 | 844 (122) | 1519 (6109) |
Management of side effects of ADT | 443 | 376 (25) | 212 (313) |
Pelvic floor physiotherapy for incontinence | 1304 | 910 (97) | 594 (2382) |
Counselling | 444 | not applicable | 444 (1629) |
Metastatic disease management | 85 | 87 (30) | not applicable |
Nutrition | 742 | 195 (31) | 361 (593) |
Exercise | 826 | 455 (70) | 674 (2167) |
*Some attendees attended the group education sessions more than once.
Conclusions
The need for PC supportive care is well recognized but may be challenging to offer when the services are fragmented and time-consuming for clinicians or staff to arrange. All modules offered by the PCSC Program can be accessed with one registration. It is convenient for patients because it is housed in one location, which also facilitates communication across disciplines. We attribute the success of our program to this model and our team approach to the individual patient’s needs.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Prostate Cancer Supportive Care Program.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2141P - Symptom burden and health-related quality of life (HRQoL) in platinum-resistant or -refractory ovarian cancer (PROC): A systematic literature review (SLR)
Presenter: Nikhila Indukuri
Session: Poster session 07
2142P - Criteria for the choice of therapeutic ceiling in the hospitalized oncology patient: Healthcare impact of the multidisciplinary committee with the Intensive Care Unit (ICU)
Presenter: María Esperanza Guirao García
Session: Poster session 07
2143P - Mortality within 30 days after last dose of intravenous systemic anti-cancer therapy: Single-center, one-year, retrospective analysis
Presenter: Osman Sutcuoglu
Session: Poster session 07
2144P - The PRognostic Oncologic Plantology (PROP) website tool predicts 30-day mortality in hospitalized cancer patients on treatment
Presenter: Oriol Mirallas
Session: Poster session 07
2145P - Thromboembolic disease associated with cyclin-dependent kinase inhibitors in patients with breast cancer
Presenter: Javier López Robles
Session: Poster session 07
2146P - Cancer-associated thrombosis clinic: Experience of the Medical Oncology Department of a hospital in Spain
Presenter: Laura Ortega Morán
Session: Poster session 07
2147P - Thrombotic recurrence and bleeding complications in non-small cell lung carcinoma (NSCLC) patients with venous thromboembolism (VTE)
Presenter: Irene Gonzalez Caraballo
Session: Poster session 07
2148P - Venous thromboembolism (VTE) in patients with advanced high grade ovarian carcinoma (aHGOC) receiving PARP inhibitors
Presenter: Lorenzo Gervaso
Session: Poster session 07
2149P - Catheter-related thrombosis in cancer patients: Data from the registry of thrombosis and neoplasia of SEOM (TESEO)
Presenter: Francisco Pelegrín Mateo
Session: Poster session 07
2150P - Clinical and molecular characterisation of cancer-associated venous thromboembolism (VTE)
Presenter: Pau Mascaró Baselga
Session: Poster session 07